REFERENCES
- Cairns J E. Trabeculectomy: Preliminary report of a surgical method of reducing intra-ocular pressure in chronic simple glaucoma without sub-conjunctival drainage of aqueous humor. Bibl Ophthalmol 1970; 81: 143–153
- Lama P J, Fechtner R D. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003; 48: 14–46
- Khaw P T, Occleston N L, Schultz G, et al. Activation and suppression of fibroblast function. Eye 1994; 8: 188–195
- Grewal D S, Jain R, Kumar H, et al. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy. Ophthalmology 2008; 115: 2141–2145
- Salmon S E, Sartorelli A C. Cancer chemotherapy. Basic and Clinical Pharmacology, ed 3, B G Katsung. Appleton and Lange, Norwalk, CT 1987; 676
- Khaw P T, Sherwood M B, Mackay S LD. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol 1992; 110: 1150–1154
- The Fluorouracil Filtering Surgery Study Group. Five-year follow up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1996; 121: 349–366
- Palanca-Capistrano A M, Hall J, Cantor L B, et al. Long-term outcomes of intraoperative 5-Fluorouracil versus intraoperative Mitomycin C in primary trabeculectomy surgery. Ophthalmology Oct 17, 2008, In press
- Chen C W, Huang H T, Sheu M M. Enhancement of IOP control effect on trabeculectomy by local application of anti-cancer drug. Acta Ophthalmol Scand 1986; 25: 1487–1491
- Salmon S E, Sartorelli A C. Cancer chemotherapy. Basic and Clinical Pharmacology, B G Katsung. Appleton and Lange, Norwalk, CT 1987; 3: 680–681
- Khaw P T, Doyle J W, Sherwood M B, et al. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin. Arch Ophthalmol 1993; 111: 263–267
- Smith M F, Doyle J W, Nguyen Q H, Sherwood M B. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery. J Glaucoma 1997; 6: 104–110
- Singh K, Mehta K, Shaikh N M, et al. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology 2000; 107: 2305–2309
- Cordeiro M F, Gay J A, Khaw P T. Human anti-transforming growth factor-beta2 antibody: A new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 1999; 40: 2225–2234
- Tripathi R C, Li J, Chan W F. Aqueous humor in glaucomatous eyes contains an increased level of TGF-B2. Exp Eye Res 1994; 59: 723–727
- A phase III study of subconjunctival human anti-transforming growth factor B2 monoclonal antibody (CAT-152) to prevent scarring after first time trabeculectomy. Ophthalmology 2007; 114: 1822–1830
- Dvorak H F, Brown L F, Detmar M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995; 146: 1029–1039
- Wong J, Wang N, Miller J W, Schuman J S. Modulation of human fibroblast activity by selected angiogenesis inhibitors. Exp Eye Res 1994; 58: 439–451
- Miki A, Oshima Y, Otori Y, et al. Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol 2008; 92: 1431–1433
- Jonas J B, Spandau U H, Schlichtenbrede F. Intravitreal bevacizumab for filtering surgery. Ophthalmic Res 2007; 39: 121–122
- Cornish K S, Ramamurthi S, Saidkasimova S. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients. Eye May 2, 2008, In press
- Scappaticci F A, Fehrenbacher L, Cartwright T. Surgical wound healing complications in metastatic colorectal cancer in patients treated with bevacizumab. J Surg Oncol 2005; 91: 173–180
- Coote M A, Ruddle J B, Qin Q. Vascular changes after intra-bleb injection of bevacizumab. J Glaucoma 2008; 17: 517–518
- Kahook M, Schuman J, Noecker R. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imagin 2006; 37(2)148–150
- Gheith M E, Siam G A, de Barros D S. Role of intravitreal bevacizumab in neovascular glaucoma. Ocul Pharmacol Ther 2007; 23: 487–491